NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. (Reporting by Dietrich Knauth Editing by Chris Reese)
Market Closed -
Other stock markets
|
Pre-market 07:53:39 | |||
90.56 EUR | -1.23% | 90.24 | -0.35% |
05-15 | Transcript : Sanofi Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM | |
05-14 | Global markets live: Apple, Sony, Vodafone, Booking, Walmart... |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.89% | 123B | |
+31.37% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.83% | 239B | |
+9.93% | 211B | |
-6.95% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts